Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/119578
Title: | Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis |
Author: | Teruel, María Simeón Aznar, Carmen Pilar Broen, Jasper C. Vonk, Madelon C. Carreira, Patricia Camps García, María Teresa García-Portales, Rosa Delgado-Frías, Esmeralda Gallego, Maria Espinosa Garriga, Gerard Spanish Scleroderma Study Group (SSSG) Beretta, Lorenzo Airó, Paolo Lunardi, Claudio Riemekasten, Gabriela Witte, Torsten Krieg, Thomas Kreuter, Alexander Distler, Jörg H.V. Hunzelmann, Nicolas Koeleman, Bobby P. C. Voskuyl, Alexandre E. Schuerwegh, Annemie J. González-Gay, Miguel A. Radstake, Timothy R.D.J. Martín, Javier Narváez García, Francisco Javier |
Keywords: | Arteritis de cèl·lules gegants Fibrosi pulmonar Esclerodèrmia Malalties autoimmunitàries Giant cell arteritis Pulmonary fibrosis Scleroderma (Disease) Autoimmune diseases |
Issue Date: | 25-Jun-2012 |
Publisher: | BioMed Central |
Abstract: | Introduction: The aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc). Methods: In total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes. Results: No evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis. Conclusions: Our results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc. |
Note: | Reproducció del document publicat a: https://doi.org/10.1186/ar3890 |
It is part of: | Arthritis Research & Therapy, 2012, vol. 14, num. 3, p. R154 |
URI: | http://hdl.handle.net/2445/119578 |
Related resource: | https://doi.org/10.1186/ar3890 |
ISSN: | 1478-6362 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
663863.pdf | 280.79 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License